142 related articles for article (PubMed ID: 35412677)
1. Quality of life in neurofibromatosis 1: development and validation of a tool dedicated to cutaneous neurofibromas in adults.
Fertitta L; Bergqvist C; Armand ML; Moryousef S; Ferkal S; Jannic A; Ravaud P; Tran VT; Ezzedine K; Wolkenstein P
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1359-1366. PubMed ID: 35412677
[TBL] [Abstract][Full Text] [Related]
2. Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.
Maguiness S; Berman Y; Rubin N; Dodds M; Plotkin SR; Wong C; Moertel C;
Neurology; 2021 Aug; 97(7 Suppl 1):S25-S31. PubMed ID: 34230204
[TBL] [Abstract][Full Text] [Related]
3. Development and preliminary evaluation of the Neurofibromatosis Type 1 Adult Quality of Life (NF1-AdQoL) questionnaire.
Crawford H; North K; Wilson MJ; Berman Y; McKelvey-Martin V; Morrison PJ; Fleming J; Barton B
Clin Exp Dermatol; 2022 Feb; 47(2):271-281. PubMed ID: 34342021
[TBL] [Abstract][Full Text] [Related]
4. [The French version of Skindex (Skindex-France). Adaptation and assessment of psychometric properties].
Leplège A; Ecosse E; Zeller J; Revuz J; Wolkenstein P
Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):177-83. PubMed ID: 12671579
[TBL] [Abstract][Full Text] [Related]
5. Validation of a Cross-cultural Adaptation of the Hair Specific Skindex-29 Scale to Spanish.
Guerra-Tapia A; Buendía-Eisman A; Ferrando J;
Actas Dermosifiliogr (Engl Ed); 2018 Jun; 109(5):424-431. PubMed ID: 29548490
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Skindex-29 Questionnaire: Portuguese Version (Portugal).
Carvalho D; Aguiar P; Palma-Carlos A
Acta Med Port; 2018 Sep; 31(9):463-469. PubMed ID: 30332369
[TBL] [Abstract][Full Text] [Related]
7. Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials.
Cannon A; Pichard DC; Wolters PL; Adsit S; Erickson G; Lessing AJ; Li P; Narmore W; Röhl C; Rosser T; Widemann BC; Blakeley JO; Plotkin SR;
Neurology; 2021 Aug; 97(7 Suppl 1):S15-S24. PubMed ID: 34230202
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional coping is related to impaired skin-related quality of life and psychological distress in patients with neurofibromatosis type 1 with major skin involvement.
Bottesi G; Spoto A; Trevisson E; Zuccarello D; Vidotto G; Cassina M; Clementi M
Br J Dermatol; 2020 Jun; 182(6):1449-1457. PubMed ID: 31329288
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.
Ferner RE; Thomas M; Mercer G; Williams V; Leschziner GD; Afridi SK; Golding JF
Health Qual Life Outcomes; 2017 Feb; 15(1):34. PubMed ID: 28193237
[TBL] [Abstract][Full Text] [Related]
10. cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.
Fertitta L; Sarin KY; Bergqvist C; Patel E; Peiffer B; Moryousef S; Armand ML; Jannic A; Ferkal S; Ravaud P; Tran VT; Blakeley JO; Romo CG; Ezzedine K; Wolkenstein P
J Invest Dermatol; 2023 Nov; 143(11):2226-2232.e1. PubMed ID: 37149083
[TBL] [Abstract][Full Text] [Related]
11. The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.
Dhaenens BAE; van Dijk SA; Taal W; Noordhoek DC; Coffey A; McKenna SP; Oostenbrink R
J Patient Rep Outcomes; 2024 Mar; 8(1):33. PubMed ID: 38499890
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous neurofibromas: patients' medical burden, current management and therapeutic expectations: results from an online European patient community survey.
Guiraud M; Bouroubi A; Beauchamp R; Bocquet A; Grégoire JM; Rauly-Lestienne I; Blanco I; Wolkenstein P; Schmitt AM
Orphanet J Rare Dis; 2019 Dec; 14(1):286. PubMed ID: 31801570
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous neurofibromas: Current clinical and pathologic issues.
Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.
Jiang C; McKay RM; Lee SY; Romo CG; Blakeley JO; Haniffa M; Serra E; Steensma MR; Largaespada D; Le LQ
J Invest Dermatol; 2023 Aug; 143(8):1369-1377. PubMed ID: 37318402
[TBL] [Abstract][Full Text] [Related]
15. Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1.
Cieza Rivera AM; Lobato Fuertes C; Fernández-Villa T; Martín Sánchez V; Atallah I
Orphanet J Rare Dis; 2024 Feb; 19(1):85. PubMed ID: 38402381
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in patients with neurofibromatosis 1 in Japan: A questionnaire survey using EQ-5D-5L.
Yoshida Y; Ehara Y; Koga M; Imafuku S
J Dermatol; 2022 Dec; 49(12):1228-1232. PubMed ID: 35781730
[TBL] [Abstract][Full Text] [Related]
17. Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials.
Thalheimer RD; Merker VL; Ly KI; Champlain A; Sawaya J; Askenazi NL; Herr HP; Da JLW; Jordan JT; Muzikansky A; Pearce EM; Sakamoto FH; Blakeley JO; Anderson RR; Plotkin SR;
Neurology; 2021 Aug; 97(7 Suppl 1):S32-S41. PubMed ID: 34230197
[TBL] [Abstract][Full Text] [Related]
18. The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases.
Cárcano CBM; de Oliveira CZ; Paiva BSR; Paiva CE
PLoS One; 2018; 13(3):e0194492. PubMed ID: 29566036
[TBL] [Abstract][Full Text] [Related]
19. A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
Fertitta L; Bergqvist C; Sarin KY; Plotkin SR; Moertel C; Petersen AK; Cannon A; Berman Y; Pichard DC; Röhl C; Lessing A; Brizion B; Peiffer B; Ravaud P; Tran VT; Armand ML; Moryousef S; Ferkal S; Jannic A; Ezzedine K; Wolkenstein P;
Br J Dermatol; 2024 Jan; 190(2):216-225. PubMed ID: 37877514
[TBL] [Abstract][Full Text] [Related]
20. Validation and Cross-cultural Adaptation of the Korean Version of the Zurich Claudication Questionnaire in Patients With Lumbar Spinal Stenosis.
Kim HJ; Lee YK; Kim DO; Chang BS; Lee CK; Yeom JS
Spine (Phila Pa 1976); 2018 Jan; 43(2):E105-E110. PubMed ID: 28525407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
